,address1,address2,city,zip,country,phone,fax,website,longBusinessSummary,fullTimeEmployees,companyOfficers,compensationAsOfEpochDate,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,beta,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,enterpriseValue,profitMargins,floatShares,sharesOutstanding,heldPercentInsiders,heldPercentInstitutions,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,netIncomeToCommon,trailingEps,enterpriseToRevenue,enterpriseToEbitda,exchange,quoteType,symbol,underlyingSymbol,shortName,longName,firstTradeDateEpochUtc,timeZoneFullName,timeZoneShortName,gmtOffSetMilliseconds,currentPrice,recommendationKey,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,totalRevenue,debtToEquity,revenuePerShare,returnOnAssets,returnOnEquity,freeCashflow,operatingCashflow,revenueGrowth,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,trailingPegRatio
0,Ashdar Building,90 Yigal Alon Street,Tel Aviv,67891,Israel,972 3 561 2212,972 3 624 2414,https://www.shl-telemedicine.com,"SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. It offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; Cardio'B, a portable device to transmit a 12-lead ECG; and Cardio Beeper 12/12, a hand-held ECG transmitter device for personal use that transmits a full ECG reading to the monitoring center. The company also provides central communication module, a telecommunication device that transmits medical data to its telemedicine centers from various medical monitoring devices; TeleWeight, a trans-telephonic weight monitoring device for personal use; TelePress, a remote blood pressure monitoring device for personal use; TeleBreather, a remote electronic handheld device to test the working of lungs; and TelePulse Oximeter, an electronic handheld diagnostic device to measure the saturation level of oxygen in blood, as well as pulse rate. It offers its telemedicine services and devices to subscribers using telephonic and internet communication technology. The company serves patients, health insurance companies, hospitals, clinics, physicians, and other health care providers. It has a collaboration agreement with Mayo Clinic to evaluate the incidence of emergency department visits, re-hospitalizations, and major adverse cardiovascular events over a period of 90 days after first hospitalization for a heart attack for patients using SmartHeart FDA approved 12 lead ECG; and the Hebrew University of Jerusalem and the Hadassah Medical Center. The company was founded in 1987 and is headquartered in Tel Aviv, Israel.",402,"{'maxAge': 1, 'name': 'Mr. Erez  Nachtomy', 'age': 60, 'title': 'CEO & Exec. Director', 'yearBorn': 1962, 'fiscalYear': 2022, 'totalPay': 426969, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,2,15.0,15.0,15.0,15.0,15.0,15.0,15.0,15.0,0.462462,70,70,97,70,70,0.0,0.0,70000,70000,220436992,4.28,16.5,3.736347,15.296552,12.017518,0.0,0.0,EUR,231878080,-0.0012899999,9292116,14403300,0.45165002,0.25909,3.793,3.9546533,1672444800,1703980800,1672444800,-76000,-0.955,3.93,-95.423,FRA,EQUITY,SZO.F,SZO.F,"SHL TELEMEDICINE  IS-,01",SHL Telemedicine Ltd.,982306800,Europe/Berlin,CEST,7200000,15.0,none,18700000,1.274,-2430000,26742000,1.564,1.811,58998000,45.104,4.057,-0.02686,0.00358,-1507375,-73000,-0.016,0.46085,-0.04119,-0.08756,USD,
1,Ashdar Building,90 Yigal Alon Street,Tel Aviv,67891,Israel,972 3 561 2212,972 3 624 2414,https://www.shl-telemedicine.com,"SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. It offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; Cardio'B, a portable device to transmit a 12-lead ECG; and Cardio Beeper 12/12, a hand-held ECG transmitter device for personal use that transmits a full ECG reading to the monitoring center. The company also provides central communication module, a telecommunication device that transmits medical data to its telemedicine centers from various medical monitoring devices; TeleWeight, a trans-telephonic weight monitoring device for personal use; TelePress, a remote blood pressure monitoring device for personal use; TeleBreather, a remote electronic handheld device to test the working of lungs; and TelePulse Oximeter, an electronic handheld diagnostic device to measure the saturation level of oxygen in blood, as well as pulse rate. It offers its telemedicine services and devices to subscribers using telephonic and internet communication technology. The company serves patients, health insurance companies, hospitals, clinics, physicians, and other health care providers. It has a collaboration agreement with Mayo Clinic to evaluate the incidence of emergency department visits, re-hospitalizations, and major adverse cardiovascular events over a period of 90 days after first hospitalization for a heart attack for patients using SmartHeart FDA approved 12 lead ECG; and the Hebrew University of Jerusalem and the Hadassah Medical Center. The company was founded in 1987 and is headquartered in Tel Aviv, Israel.",402,"{'maxAge': 1, 'name': 'Mr. Amir  Hai', 'age': 56, 'title': 'Chief Financial Officer', 'yearBorn': 1966, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,2,15.0,15.0,15.0,15.0,15.0,15.0,15.0,15.0,0.462462,70,70,97,70,70,0.0,0.0,70000,70000,220436992,4.28,16.5,3.736347,15.296552,12.017518,0.0,0.0,EUR,231878080,-0.0012899999,9292116,14403300,0.45165002,0.25909,3.793,3.9546533,1672444800,1703980800,1672444800,-76000,-0.955,3.93,-95.423,FRA,EQUITY,SZO.F,SZO.F,"SHL TELEMEDICINE  IS-,01",SHL Telemedicine Ltd.,982306800,Europe/Berlin,CEST,7200000,15.0,none,18700000,1.274,-2430000,26742000,1.564,1.811,58998000,45.104,4.057,-0.02686,0.00358,-1507375,-73000,-0.016,0.46085,-0.04119,-0.08756,USD,
2,Ashdar Building,90 Yigal Alon Street,Tel Aviv,67891,Israel,972 3 561 2212,972 3 624 2414,https://www.shl-telemedicine.com,"SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. It offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; Cardio'B, a portable device to transmit a 12-lead ECG; and Cardio Beeper 12/12, a hand-held ECG transmitter device for personal use that transmits a full ECG reading to the monitoring center. The company also provides central communication module, a telecommunication device that transmits medical data to its telemedicine centers from various medical monitoring devices; TeleWeight, a trans-telephonic weight monitoring device for personal use; TelePress, a remote blood pressure monitoring device for personal use; TeleBreather, a remote electronic handheld device to test the working of lungs; and TelePulse Oximeter, an electronic handheld diagnostic device to measure the saturation level of oxygen in blood, as well as pulse rate. It offers its telemedicine services and devices to subscribers using telephonic and internet communication technology. The company serves patients, health insurance companies, hospitals, clinics, physicians, and other health care providers. It has a collaboration agreement with Mayo Clinic to evaluate the incidence of emergency department visits, re-hospitalizations, and major adverse cardiovascular events over a period of 90 days after first hospitalization for a heart attack for patients using SmartHeart FDA approved 12 lead ECG; and the Hebrew University of Jerusalem and the Hadassah Medical Center. The company was founded in 1987 and is headquartered in Tel Aviv, Israel.",402,"{'maxAge': 1, 'name': 'Mr. Linus  Drop', 'age': 49, 'title': 'Co-Managing Director of SHL Telemedizin Germany', 'yearBorn': 1973, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,2,15.0,15.0,15.0,15.0,15.0,15.0,15.0,15.0,0.462462,70,70,97,70,70,0.0,0.0,70000,70000,220436992,4.28,16.5,3.736347,15.296552,12.017518,0.0,0.0,EUR,231878080,-0.0012899999,9292116,14403300,0.45165002,0.25909,3.793,3.9546533,1672444800,1703980800,1672444800,-76000,-0.955,3.93,-95.423,FRA,EQUITY,SZO.F,SZO.F,"SHL TELEMEDICINE  IS-,01",SHL Telemedicine Ltd.,982306800,Europe/Berlin,CEST,7200000,15.0,none,18700000,1.274,-2430000,26742000,1.564,1.811,58998000,45.104,4.057,-0.02686,0.00358,-1507375,-73000,-0.016,0.46085,-0.04119,-0.08756,USD,
3,Ashdar Building,90 Yigal Alon Street,Tel Aviv,67891,Israel,972 3 561 2212,972 3 624 2414,https://www.shl-telemedicine.com,"SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. It offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; Cardio'B, a portable device to transmit a 12-lead ECG; and Cardio Beeper 12/12, a hand-held ECG transmitter device for personal use that transmits a full ECG reading to the monitoring center. The company also provides central communication module, a telecommunication device that transmits medical data to its telemedicine centers from various medical monitoring devices; TeleWeight, a trans-telephonic weight monitoring device for personal use; TelePress, a remote blood pressure monitoring device for personal use; TeleBreather, a remote electronic handheld device to test the working of lungs; and TelePulse Oximeter, an electronic handheld diagnostic device to measure the saturation level of oxygen in blood, as well as pulse rate. It offers its telemedicine services and devices to subscribers using telephonic and internet communication technology. The company serves patients, health insurance companies, hospitals, clinics, physicians, and other health care providers. It has a collaboration agreement with Mayo Clinic to evaluate the incidence of emergency department visits, re-hospitalizations, and major adverse cardiovascular events over a period of 90 days after first hospitalization for a heart attack for patients using SmartHeart FDA approved 12 lead ECG; and the Hebrew University of Jerusalem and the Hadassah Medical Center. The company was founded in 1987 and is headquartered in Tel Aviv, Israel.",402,"{'maxAge': 1, 'name': 'Mr. Bernd  Altpeter', 'title': 'Co-Managing Director of SHL Telemedizin Germany', 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,2,15.0,15.0,15.0,15.0,15.0,15.0,15.0,15.0,0.462462,70,70,97,70,70,0.0,0.0,70000,70000,220436992,4.28,16.5,3.736347,15.296552,12.017518,0.0,0.0,EUR,231878080,-0.0012899999,9292116,14403300,0.45165002,0.25909,3.793,3.9546533,1672444800,1703980800,1672444800,-76000,-0.955,3.93,-95.423,FRA,EQUITY,SZO.F,SZO.F,"SHL TELEMEDICINE  IS-,01",SHL Telemedicine Ltd.,982306800,Europe/Berlin,CEST,7200000,15.0,none,18700000,1.274,-2430000,26742000,1.564,1.811,58998000,45.104,4.057,-0.02686,0.00358,-1507375,-73000,-0.016,0.46085,-0.04119,-0.08756,USD,
